# Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis

> **NCT06989333** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Jiuwu Bai** · enrollment: 10 (estimated)

## Conditions studied

- Pulmonary Alveolar Proteinosis

## Interventions

- **DRUG:** GM-CSF (granulocyte-macrophage colony-stimulating factor)

## Key facts

- **NCT ID:** NCT06989333
- **Lead sponsor:** Jiuwu Bai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06989333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06989333, "Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06989333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*